Mouse Study Suggests Common Fungus Could Worsen Respiratory Infections
By Brandon Levy
Tuesday, September 29, 2020
Throughout the COVID-19 pandemic, both scientists and the media have focused on the factors that influence who experiences mild symptoms or none at all and who faces potentially life-threatening consequences from the disease. Other respiratory viruses like the flu also have widely varying effects on different patients. New IRP research has found that exposure to a common variety of mold primes the immune system to overreact to the flu virus, dramatically increasing the illness’s severity.
Infectious Disease Expert Interviewed by NBA Superstar
By Brandon Levy
Wednesday, April 1, 2020
As the COVID-19 illness has continued to spread, so has anxiety, fear, and uncertainty. Now more than ever, we need communicators who can provide clear explanations about the latest research and public health guidelines.
IRP senior investigator Anthony Fauci, Ph.D., has been one of the most prominent voices providing information about the novel coronavirus over the past several weeks. Dr. Fauci, who serves as director of the NIH’s National Institute of Allergy and Infectious Diseases (NIAID), seems to be doing everything he can to make sure the American public has the best information available about the current situation, from speaking at White House press briefings to appearing on television shows like The Daily Show with Trevor Noah. Last Thursday, March 26, Dr. Fauci participated in a live Q&A with NBA superstar Stephen Curry on Curry’s Instagram page. Read on for a few highlights from their discussion, or click on the video below to watch the entire conversation.
Six Questions With Dr. Matthew Memoli
By Brooke Worthing
Thursday, August 22, 2019
We all know flu season as the time of year where people are loading up on hand sanitizer and heading to the doctor for their flu shot. However, many underestimate the severity of the flu. During a typical flu season, five to twenty percent of Americans fall ill, leading to more than 200,000 hospitalizations and 36,000 deaths. Because of this serious threat to the public, the IRP has a long track record of researching vaccines, antivirals, diagnostics, and other resources in an effort to prevent individuals from catching the flu and improve care for those who do.
By Michele Lyons
Tuesday, March 26, 2019
As Women's History month draws to a close, we’d like to introduce you to some of the IRP researchers who have received the honor of delivering the Anita B. Roberts Lecture. The Anita B. Roberts Lecture Series is organized by the NIH Women Scientist Advisors Committee to highlight outstanding research achievements by female scientists at NIH. The series is supported by the Office of Research on Women’s Health.

By Jeanelle Spencer
Saturday, December 13, 2014
This is National Influenza Vaccination Week. Since we are in the midst of flu season, it is an appropriate time to highlight the importance of continuing influenza vaccination. I won’t go into the details of the NIH Foil the Flu campaign, the annual flu vaccination clinic sponsored by the Office of Research Services that provides all NIH staff and contractors with the seasonal flu vaccine for free. Instead, I’d like to highlight the importance of influenza research and a couple of intramural investigators who are tackling interesting questions along the pipeline to creating safe and effective influenza vaccines.
